Abacavir Sulfate (188062-50-2): A Deep Dive

Abacavir compound sulfate, identified by the CAS number 188062502 , is a crucial antiviral utilized in the treatment of HIV illness. Its mechanism of mode involves inhibiting reverse transcription , a vital protein for viral reproduction . Patients receiving this substance must undergo genetic testing prior to commencement, due to a risk of hypersensitivity sensitivity linked to the HLA-B*57:01 allele. This complication can range from mild skin irritation to a severe, life-threatening emergency. Careful observation and patient education are therefore critical for safe and beneficial utilization of abacavir compound.

Abarelix: Understanding Compound 183552-38-7

Abarelix, identified as compound 183552-38-7, is a laboratory-created decapeptide developed for the therapy of benign ALCAFTADINE  147084-10-4 prostatic hyperplasia . This compound functions as a targeted gonadotropin-releasing hormone (GnRH) blocker , effectively diminishing testosterone production. Research into the molecule has focused on its ability to lessen associated conditions and potentially provide an alternative to conventional interventions. The molecular profile of 183552-38-7 is intricate, showcasing a distinct amino acid sequence resulting in its targeted mechanism of impact. More clinical trials are being conducted to fully assess its extended well-being and efficacy .

Abiraterone Acetate: Properties and Identification via CAS 154229-18-2

Abiraterone salt is a copyrightal antagonist of CYP17A1, an enzyme crucial for testosterone biosynthesis. Its molecular formula is C26H30O3, and it’s frequently identified by its Chemical Abstracts Service (CAS) Registry Number 154229-18-2, providing a identifier for reliable identification. The medication 's properties include notable affinity for CYP17A1, resulting in decreased androgen levels and exhibiting the white to off-white crystalline form appearance. Further analysis using analytical methods is often conducted to confirm identity and consistency.

CAS Number Spotlight: Abacavir Sulfate – 188062-50-2

This article focuses on a significant pharmaceutical substance: Abacavir Sulfate Form, identified by its unique Chemical Abstracts Service (CAS) number : 188062-50-2. This agent is a essential part in the treatment of HIV infection, frequently used in conjunction other reverse transcriptase inhibitor medications . Knowing this chemical code is important for professionals in the pharmaceutical sector .

Key points regarding Abacavir Sulfate Salt :

  • Purpose: Acts as a nucleoside reverse transcriptase suppressor.
  • Use : Primarily used in AIDS treatment .
  • Identification : The unique number 188062-50-2 provides accurate labeling .

Investigating Abarelix: Organic Identity (183552-38-7)

Abarelix, identified by the registration designation 183552-38-7, represents a fascinating example within the realm of decapeptide science. Its detailed configuration is crucial to its biological function. Broadly, this entity is a synthetic decapeptide, designed to target and block gonadotropin-releasing hormone. The molecular formula reveals a sequence of amino acids carefully positioned to achieve a specific binding with the GnRH receptor.

  • Greater analysis are conducted to fully elucidate its mode of influence.
  • Understanding its manufacture is vital for increasing production.
  • The exact chain dictates its potency.

Abiraterone Compound (154229-18-2): Applications and Molecular Profile

{Abiraterone Acetate , with the CAS number 154229-18-2, is a medication primarily indicated in the treatment of metastatic gland malignancy , specifically those demonstrating mutations in the phosphatase tensin pathway. It functions as an blocker of copyrightal P450c17, an enzyme crucial for testosterone creation. Chemically, it’s a laboratory-created compound with a complex makeup, designed to effectively reduce androgen levels. Its therapeutic purpose has significantly enhanced outcomes for patients with metastatic prostate malignancy.

Leave a Reply

Your email address will not be published. Required fields are marked *